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Introduction {#sec1-1}
============

As part of the central nervous system, the spinal cord is crucial for conveying afferent and efferent impulses between the brain and somatic/visceral receptors, as well as executing reflexes. However, its vulnerability and limited capacity for regeneration and self-renewal makes recovery from mechanical trauma difficult. Indeed, severe spinal cord injury (SCI) often results in permanent functional impairment, such as motor/sensory dysfunction or bladder and rectal disturbances (Bastien et al., 2015; Jain et al., 2015; He and Jin, 2016). Thus, SCI can diminish a patient's quality of life and cause a heavy burden for families (Qiu, 2009). For decades, doctors and patients have been searching for effective interventions and therapies for SCI that do not exhibit serious side effects. However, because of limitations in therapeutic applications, there are currently no available therapies for an effective recovery (Wyndaele and Wyndaele, 2006; Courtine et al., 2011; Yang et al., 2016). Schwab (2002) suggested four principal strategies for SCI repair: promoting regrowth of interrupted nerve fiber tracts, bridging spinal cord lesions, repairing damaged myelin, and restoring nerve-fiber impulse conductivity. Some promising therapeutic interventions, such as cell transplantation and metabolic interventions, have shown effectiveness in animal models (Zhang et al., 2009; Guerrero et al., 2012; Tsukahara et al., 2017; Nordestgaard et al., 2018). Nevertheless, these potential therapies must be further tested in animal models and validated in human clinical trials.

Clarifying the pathological and molecular changes after SCI is crucial because the endogenous mechanisms for repair and intervention may provide potent insight for therapy exploration. Injury can elicit inflammatory stimuli, which then influence the production of proinflammatory cytokines and other mediators (Peifer et al., 2006). Localized immune/inflammatory responses are important contributions to secondary tissue damage and functional deficits after SCI (Ghasemlou et al., 2010), and are also essential for cleaning tissue debris and remodeling and repair after injury. Previous studies (Carlson et al., 1998; Schnell et al., 1999; Hashimoto et al., 2003, 2005) have shown that the lesion phase can be divided into three stages. First, neutrophil infiltration and cell death dramatically increase (Liu et al., 1997). Second, macrophages/microglia accumulate and proliferate, which can result in harmful effects on surrounding tissues. Third, glial scars form, in which astrocytes play a harmful role in tract regeneration by surrounding the injured tissue and producing scar-associated compounds. The characteristics of inflammation and extent of glial scar formation represent the most distinct differences between the acute, sub-acute, and chronic phases of the SCI microenvironment. Hence, microenvironmental changes after SCI may affect prognosis (Nishimura et al., 2013), and must be considered for functional recovery at different stages.

Recently, gene profiling studies have suggested that gene expression and signaling pathways are substantially changed after SCI (Di Giovanni et al., 2003; Byrnes et al., 2011; Lee-Liu et al., 2014), and may influence the microenvironment of the injury site. Microarray analyses have provided novel perspectives on diagnosis, therapy, and prognosis prediction for SCI (Nesic et al., 2002; Xiao et al., 2005). However, differentially expressed genes (DEGs) are rarely consistent across different studies (Nesic et al., 2002; Di Giovanni et al., 2003; Xiao et al., 2005; Byrnes et al., 2011; Lee-Liu et al., 2014; Duran et al., 2017), and many important genes and pathways have not been thoroughly investigated. As DEGs may provide therapeutic targets, exact changes in the gene transcriptome and the underlying cellular and molecular mechanisms still need to be clarified, compared, and critically analyzed for different time points, especially the acute, sub-acute and chronic phases.

In the present study, we focused on alterations in gene expression in the thoracic spinal segment (T8) of the mouse spinal cord at six different time points (0.5, 4, and 24 hours, 3, 7, and 28 days) after SCI, because alterations at these time points are likely related to pathological changes associated with SCI. In this study, we compared gene expression patterns at different time points and analyzed them using bioinformatic methods, particularly from a protein-protein interaction perspective. The aim of our study was to identify potential genes/pathways and clarify the mechanisms underlying SCI at the molecular level.

Materials and Methods {#sec1-2}
=====================

Retrieval of microarray dataset {#sec2-1}
-------------------------------

The microarray dataset, GSE5296, was downloaded from the Gene Expression Omnibus DataSet from the National Center for Biotechnology Information Database (<http://www.ncbi.nlm.nih.gov/gds/>). GPL1261 (Affymetrix Mouse Genome 430 2.0 Array) (Affymetrix Inc., Santa Clara Valley, CA, USA) was used as the platform. C57BL/6 mice were used as subjects. All animals were deeply anesthetized during surgery under isoflurane anesthesia. Moderate injury was delivered to each SCI mouse at T8. Mice were then sacrificed at the following time points: 0.5, 4, and 24 hours, and 3, 7, and 28 days (*n* = 3/per subgroup). Tissue samples from the impact site (0.4 cm in length) were collected after sacrifice. Each individual was pooled (4 mice in total), and 12 mice were prepared at each time point. A control group (*n* = 2/per subgroup) that underwent sham injury was included.

DEG profiling in tissue from the SCI impact site {#sec2-2}
------------------------------------------------

Raw data were downloaded, and R/Bioconductor software (v3.4.1, R Foundation, Vienna, Austria) (Gregory Alvord et al., 2007; Barrett et al., 2013) was used to check the data quality. The software indicates whether the quality of each selected CEL was sufficient (**Additional Figure 1**). gcRobust Multi-array Average (gcRMA) analysis was used as the normalization algorithm for gene expression profiling, and the limma algorithm package was used for DEG identification (Gregory Alvord et al., 2007; Barrett et al., 2013). Spinal cord tissue from sham injury mice was used as the control. DEGs were defined as genes with at least 2-fold changed expression, with P-values \< 0.05 between the control group and any subgroup at six time points. Hierarchical clustering analyses were also performed for DEGs.

###### 

Quality control of the CEL files in GSE5296 dataset based on R/Bioconductor program.

\(A\) Summarization of Quality control. (B) Plot of gcRobust Multi-array Average (gcRMA) algorithm. (C) RNA degradation plot. (D) Cluster Dengrogram. (E) Principal components plot.

###### 

Click here for additional data file.

Functional enrichment analysis of DEGs {#sec2-3}
--------------------------------------

The bioinformatics resource, Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang da et al., 2009) (<https://david.ncifcrf.gov/>) was used for functional annotation. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and Gene Ontology (GO) analysis were used to identify genes of interest. Enriched terms for KEGG pathway and GO analysis were collected, including Gene Ontology Biological Process, Cellular Components, and Molecular Function (abbreviated as GO_BP, GO_CC, and GO_MF). Those with P-values \< 0.05 were considered significantly enriched terms.

Prediction and analysis of transcription factors {#sec2-4}
------------------------------------------------

Based on the Animal Transcription Factor Database (TFDB) (<http://bioinfo.life.hust.edu.cn/AnimalTFDB/>) (Zhang et al., 2015), DEGs that were transcription factors were identified. Interaction networks of DEGs were also constructed using Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (Franceschini et al., 2013) (v10.5) and Cytoscape software (Smoot et al., 2011) (v3.6.0; National Institute of General Medical Science, Bethesda, MD, USA) to identify protein-protein interactions. The score threshold was set to 0.04.

Statistical analysis {#sec2-5}
--------------------

All statistical analyses were performed using GraphPad Prism software (v6; GraphPad Software, San Diego, CA, USA) and SPSS software (v20.0; IBM SPSS Inc., Chicago, IL, USA). P-values \< 0.05 were considered statistically significant.

Results {#sec1-3}
=======

Identification of DEGs from SCI site tissue {#sec2-6}
-------------------------------------------

The gene expression dataset, GSE5296, was used to identify DEGs from a SCI murine model using a microarray representing approximately 34,000 genes. By comparing the control group and SCI subgroups at each time point, several DEGs were identified, with the numbers shown in **[Figure 1](#F1){ref-type="fig"}**. SCI led to upregulation of 2,460 genes in injured spinal cord at 7 days after injury, 109 of which were upregulated at each time point. Moreover, many of these upregulated genes were associated with inflammation. In total, 2010 genes were downregulated at the injury site at 7 days following SCI, 30 of which were downregulated at each time point. Interestingly, the number of downregulated genes was always smaller than the number of upregulated genes at each time point. Overall, we identified 109 upregulated genes and 30 downregulated genes with consistent directions of variation at each time point (**[Figure 2](#F2){ref-type="fig"}**). **[Additional Table 1](#T1){ref-type="table"}** contains the complete list of DEGs.

![DEGs at the injury site in mice.\
The GSE5296 dataset contained a control group (sham injury) (*n* = 2/time point) and SCI group with six subgroups at different time points (including 0.5, 4, and 24 h, and 3, 7, and 28 d; *n* = 3/time point). DEGs between each SCI subgroup and control group were identified using the limma algorithm package of R/Bioconductor software. DEGS were defined as genes with at least 2-fold changed expression levels and *P*-values \< 0.05. DEGs: Differentially expressed genes; SCI: spinal cord injury; h: hours; d: days.](NRR-14-1262-g002){#F1}

![Bi-cluster analysis of DEGs with consistent directions of variation at each time point following SCI compared with the control group.\
Each row represents one DEG, and each column represents a tissue sample of T8 spinal cord from injured and sham-injured spinal cord. Control tissue was from sham-injured spinal cord. SCI tissue was from injured T8 spinal cord tissue. "SCI0.5h", "SCI4h", "SCI24h", "SCI3d", "SCI7d", and "SCI28d" tissues were collected at 0.5, 4, and 24 hours, and 3, 7, and 28 days following SCI, respectively. The numbers 1, 2, and 3 represent biological repetitions. The heat map was constructed based on DEG expression values in each tissue sample. DEGs: Differentially expressed genes; SCI: spinal cord injury; h: hours; d: days.](NRR-14-1262-g003){#F2}

###### 

Differentially expressed genes with consistent directions of variation at each time point after T8 SCI

                         Symbols
  ---------------------- ---------------
  Up-regulated genes     1810011010Rik
                         3930401B19Rik
                         A130040M12Rik
                         Ada
                         Adamts1
                         Akr1b8
                         Arid5a
                         Atf3
                         Batf3
                         Birc3
                         C230007H23Rik
                         C5ar1
                         Casp4
                         Ccl12
                         Ccl2
                         Ccl3
                         Ccl4
                         Ccl9
                         Cd14
                         Cebpb
                         Cebpd
                         Ch25h
                         Cp
                         Ctla2a
                         Ctla2b
                         Ctse
                         Cxcl1
                         Cxcl10
                         Cxcl16
                         Cyr61
                         Cytip
                         D17H6S56E-5
                         Dusp3
                         Dusp6
                         Egr2
                         Elavil
                         Fnl
                         Fos
                         Fosl2
                         Gadd45g
                         Galnt2
                         Galnt7
                         Gch1
                         Glipr1
                         Gm20186
                         Gpr65
                         Gpr84
                         H2-Aa
                         H2-Ab1
                         Hmgb2
                         Icam1
                         Id1
                         Ier2
                         Irf2bp2
                         Itga5
                         Itgam
                         Jun
                         Junb
                         Klf6
                         Lasp1
                         Lcn2
                         Lmna
                         Lrgl
                         Maff
                         Map3k8
                         Mcll
                         Mpzl2
                         Ms4a6d
                         Myc
                         Nes
                         Nfkbiz
                         Nras
                         Nrros
                         Ogfr
                         Peak1
                         Plala
                         Plaur
                         Plek
                         Plin4
                         Ptbp3
                         Ptgs2
                         Rab20
                         Rap2b
                         Rgs1 Rhoj
                         Rrad
                         S100a10
                         Sbno2
                         Sdc4
                         Sec61a1
                         Serpine1
                         Sgk1
                         Snx18
                         Socs3
                         Srgn
                         Stat3
                         Stom
                         Tgifl
                         Thbsl
                         Timp3
                         Tlrl3
                         Tlr2
                         Tnfrsf12a
                         Tribl
                         Trp53
                         Tubb6
                         Wwtrl
                         Xdh
                         Zfp36
  Down-regulated genes   1700056N10Rik
                         4833408G04Rik
                         6720422M22Rik
                         Agbl5
                         AI480526
                         B830017H08Rik
                         BC030500
                         CdhlO
                         Cilp
                         D630023F18Rik
                         Dgkg
                         Dnajc21
                         Dtxl
                         Erdrl
                         Faml63a
                         Gprl2
                         Grin2b
                         Hemgn
                         Midi1
                         Pdp2
                         Pou4f1
                         Prr36
                         Rhox4b
                         Smtnl2
                         Tfdp2
                         Trhde\`
                         Ttc3
                         Upp2
                         Wwox
                         Xist

Functional annotation of DEGs in SCI site tissue {#sec2-7}
------------------------------------------------

Using the DAVID tool, enriched KEGG and GO terms were identified from the DEGs. **[Figure 3](#F3){ref-type="fig"}** shows the number of KEGG and GO terms that were enriched in each SCI subgroup. The results indicate a peak on day 7, which is similar to the tendency shown by the DEGs. For each SCI subgroup, the three KEGG pathways showing highest changes in enrichment scores are listed in **[Additional Table 2](#T2){ref-type="table"}**. Similarly, those for the GO terms are shown in **[Additional Table 3](#T3){ref-type="table"}**. Notably, KEGG analysis revealed that genes related to metabolic pathways were downregulated on day 7, with metabolic pathways also showing the largest number of enriched genes. This was also the finding on day 28. Some genes related to inflammatory processes were upregulated on either day 7 or 28 after SCI, with the majority of these genes upregulated at both time points.

![Overview of KEGG and GO terms enriched at each time point of spinal cord injury compared with the control group.\
All enrichment analyses were based on upregulated and downregulated genes with *P*-values \< 0.05. KEGG: Kyoto Encyclopedia of Genes and Genomes; GO: Gene Ontology; h: hours; d: days.](NRR-14-1262-g004){#F3}

###### 

The 3 KEGG pathway terms with the highest changes in enrichment scores at each SCI sub-group

  Sub-groups                         DEGs                         KEGG terms                        P                                                                                          Fold Enrichment                                                               Genes
  ---------------------------------- ---------------------------- --------------------------------- ------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------- ---------------------------------------------------------------------------------------
  0.5 h                              Upregulated Genes            TNF signaling pathway             0.0000                                                                                      8.2443                                                                       CXCL1, ICAM1, IL6, CEBPB, CCL2, TNF, PTGS2, SOCS3, MAP2K3, CXCL2, EDN1, NFKBIA, ...
  Legionellosis                      0.0000                        7.8827                           CXCL1, IL6, TNF, CXCL2, TLR2, IL1B, NFKBIA, HSPA1A, HSPA1B, ITGAM, CD14                                                                                                  
  Leishmaniasis                      0.0000                        7.6587                           FOS, TNF, PTGS2, NCF1, JUN, TLR2, IL1B, NFKBIA, H2-AA, H2-AB1, ITGAM, IL1A                                                                                               
  Downregulated Gene                 ECM-receptor interaction     0.0223                             6.4983                                                                                    TNC, COL2A1, COL1A1, SV2C                                                     
  Amoebiasis                         0.0083                        6.1095                           RAB7B, ACTN1, GNAS, COL2A1, COL1A1                                                                                                                                       
  Proteoglycans in cancer            0.0123                        4.2255                           LUM, IGF1, COL1A1, FZD2, MMP2, KDR                                                                                                                                       
  4 h                                Upregulated Genes            Glycosaminoglycan degradation     0.0003                                                                                      4.8513                                                                       GNS, ARSB, NAGLU, HPSE, GUSB, HEXA, HEXB, GALNS, GLB1
  Leishmaniasis                      0.0000                        4.7755                           PTGS2, C3, TLR2, NFKBIA, TLR4, ITGB2, ITGB1, TGFB1, ITGAM, FOS, MYD88, IL1B, IFNGR1, ...                                                                                 
  Staphylococcus aureus infection    0.0000                        4.7543                           ICAM1, C3AR1, C5AR1, C3, FCGR4, ITGB2, H2-AB1, FCGR1, C1QC, ITGAM, FCGR3, C1QA, ...                                                                                      
  Downregulated Genes                Steroid biosynthesis         0.0000                             18.8585                                                                                   TM7SF2, CYP51, SC5D, MSMO1, SQLE, DHCR7, LSS, HSD17B7, DHCR24, NSDHL, FDFT1   
  Terpenoid backbone biosynthesis    0.0000                        9.9138                           FNTB, MVD, HMGCR, FDPS, HMGCS1, MVK, IDI1                                                                                                                                
  Nicotine addiction                 0.0000                        8.9578                           SLC32A1, GABRA1, GRIN2B, GABRA3, GABRB2, GRIN2C, GRIN2D, GRIN1, CHRNA4, CHRNA7, ...                                                                                      
  24 h                               Upregulated Genes            Malaria                           0.0000                                                                                      6.9027                                                                       CSF3, SELP, ICAM1, IL6, CCL2, MET, TLR2, ACKR1, TLR4, ITGB2, TGFB1, VCAM1, CCL12, ...
  TNF signaling pathway              0.0000                        5.9275                           CXCL1, CSF2, CCL2, PTGS2, CSF1, CXCL3, CXCL2, EDN1, NFKBIA, NFKB1, CCL5, CXCL10, ...                                                                                     
  Legionellosis                      0.0000                        5.5222                           CXCL1, IL6, RELA, CXCL3, HBS1L, CXCL2, TLR2, NFKBIA, NFKB1, TLR4, ITGB2, HSPA1A, ...                                                                                     
  Downregulated Gene                 Hedgehog signaling pathway   0.0245                             6.2764                                                                                    PTCH1, GAS1, HHIP, GLI2                                                       
  Basal cell carcinoma               0.0001                        6.1623                           BMP4, WNT5A, WNT4, PTCH1, FZD2, HHIP, GLI2, AXIN2, FZD6                                                                                                                  
  Fatty acid elongation              0.0302                        5.7936                           HACD4, ACOT2, ELOVL7, ELOVL6                                                                                                                                             
  3 d                                Upregulated Genes            DNA replication                   0.0000                                                                                      4.7563                                                                       POLE, POLA1, MCM2, MCM3, MCM4, MCM5, MCM6, RFC5, POLD3, DNA2, POLD4, RFC3, ...
  Staphylococcus aureus infection    0.0000                        3.9536                           SELP, ICAM1, C3AR1, C5AR1, FCGR4, FPR1, ITGB2, H2-AB1, FPR2, FCGR1, C1QC, ITGAM, ...                                                                                     
  Leishmaniasis                      0.0000                        3.9016                           PTPN6, PTGS2, NCF2, NCF1, NCF4, TLR2, FCGR4, NFKBIA, TLR4, ITGB2, H2-AB1, STAT1, ...                                                                                     
  Downregulated Gene                 Nicotine addiction           0.0000                             7.8355                                                                                    GABRG1, GABRG2, GABRA2, GABRA1, GABRA4, GABRB2, GABRB1, GRIN1, GABRA5, ...    
  Cocaine addiction                  0.0000                        5.0497                           CDK5R1, DRD2, MAOA, ADCY5, MAOB, GRIN1, GRIN3B, GRIN3A, GRM3, GRIA2, GRIN2B, ...                                                                                         
  Retrograde endocannabinoid signa   0.0000                        4.8046                           ADCY3, GABRB2, GABRB1, ABHD6, ADCY5, GNG13, KCNJ3, RIMS1, GNG8, CNR1, MGLL, ...                                                                                          
  7 d                                Upregulated Genes            DNA replication                   0.0000                                                                                      4.1957                                                                       LIG1, POLE, POLA1, MCM2, POLA2, MCM3, MCM4, MCM5, MCM6, PRIM1, RFC5, POLD3, ...
  Other glycan degradation           0.0020                        3.4964                           AGA, MAN2B2, HEXA, HEXB, MAN2B1, FUCA1, MANBA, GBA, GLB1                                                                                                                 
  Glycosaminoglycan degradation      0.0014                        3.3299                           GNS, ARSB, NAGLU, HYAL2, HPSE, GUSB, HEXA, HEXB, GALNS, GLB1                                                                                                             
  Downregulated Genes                Nicotine addiction           0.0000                             7.7072                                                                                    GABRG2, GABRG3, GABRA1, GABRB3, GABRB2, GABRA3, GABRB1, GRIN1, GABRA5, ...    
  Steroid biosynthesis               0.0000                        6.7607                           CYP51, SC5D, MSMO1, SQLE, DHCR7, LSS, HSD17B7, NSDHL, DHCR24, FDFT1                                                                                                      
  Retrograde endocannabinoid signa   0.0000                        4.8637                           ADCY1, ADCY2, GABRB3, GABRB2, GNAI1, GABRB1, ADCY5, GNG13, RIMS1, KCNJ3, ...                                                                                             
  28 d                               Upregulated Genes            Staphylococcus aureus infection   0.0000                                                                                      4.3360                                                                       ITGAL, ICAM1, C3AR1, C5AR1, C3, FCGR4, ITGB2, H2-AB1, FCGR1, C1QC, ITGAM, FCGR3, ...
  Leishmaniasis                      0.0000                        4.2712                           PTGS2, C3, TLR2, TLR4, ITGB2, ITGB1, TGFB1, ITGAM, IRAK4, FOS, MYD88, IFNGR2, ...                                                                                        
  Other glycan degradation           0.0016                        4.1894                           MAN2B2, HEXA, HEXB, MAN2B1, FUCA1, MANBA, GBA, GLB1                                                                                                                      
  Downregulated Genes                Steroid biosynthesis         0.0000                             15.2542                                                                                   TM7SF2, CYP51, SC5D, MSMO1, SQLE, DHCR7, LSS, HSD17B7, NSDHL, DHCR24, FDFT1   
  Nicotine addiction                 0.0000                        9.8805                           GABRG3, GABRA1, GABRA3, GABRB2, GABRA5, GRIN1, GRIA4, GRIN3A, SLC32A1, ...                                                                                               
  Terpenoid backbone biosynthesis    0.0014                        6.8734                           MVD, HMGCR, FDPS, HMGCS1, MVK, IDI1                                                                                                                                      

###### 

The 3 GO terms with the highest changes in enrichment scores at each SCI sub-group

  Sub-groups                                                                              DEGs                                                                            Category                                               GO terms                                                                           *P*                                     Fold Enrichment                       Genes
  --------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------------------------------- --------------------------------------- ------------------------------------- --------------------------------------------------
  0.5 h                                                                                   Upregulated Genes                                                               GO_BP                                                  positive regulation of TRAIL-activated apoptotic signaling pathway                 0.0012                                  49.0027                               ATF3, TIMP3, PTEN
  cellular response to cycloheximide                                                      0.0012                                                                          49.0027                                                KLF2, MYC, KLF4                                                                                                                                                  
  positive regulation of cell aging                                                       0.0403                                                                          49.0027                                                TRP53, LMNA                                                                                                                                                      
  GO_CC                                                                                   neuronal cell body membrane                                                     0.0023                                                 8.8052                                                                             ATP2B1, KCNA2, KCNB1, HPCA, CX3CR1                                            
  microtubule associated complex                                                          0.0153                                                                          7.5659                                                 NDEL1, MAP1B, PAFAH1B1, RANBP2                                                                                                                                   
  nuclear euchromatin                                                                     0.0203                                                                          6.8094                                                 JUN, MYC, KLF4, SMARCA4                                                                                                                                          
  GO_MF                                                                                   C-4 methylsterol oxidase activity                                               0.0424                                                 46.5227                                                                            MSMO1, CH25H                                                                  
  CCR2 chemokine receptor binding                                                         0.0027                                                                          34.8920                                                CCL12, CCL2, CCL7                                                                                                                                                
  MRF binding                                                                             0.0065                                                                          23.2613                                                TSC22D3, CREBBP, BHLHE40                                                                                                                                         
  Downregulated Genes                                                                     GO_BP                                                                           intramembranous ossification                           0.0005                                                                             86.9327                                 COL1A1, AXIN2, MMP2                   
  endothelium development                                                                 0.0282                                                                          69.5462                                                SLC40A1, KDR                                                                                                                                                     
  peripheral nervous system axon regeneration                                             0.0282                                                                          69.5462                                                TNC, MMP2                                                                                                                                                        
  GO_CC                                                                                   cytoplasmic microtubule                                                         0.0360                                                 9.9504                                                                             BIRC5, MID1, AXIN2                                                            
  nuclear envelope                                                                        0.0096                                                                          5.9828                                                 TRPC2, AGPAT5, CHIL3, RRM2, TFDP2                                                                                                                                
  extracellular matrix                                                                    0.0009                                                                          5.1444                                                 LPL, LUM, TNC, CILP, COL2A1, COL1A1, MFAP4, ...                                                                                                                  
  GO_MF                                                                                   tRNA (guanine-N2-)-methyltransferase activity                                   0.0171                                                 115.1551                                                                           TRMT1L, TRMT11                                                                
  glycine binding                                                                         0.0033                                                                          34.5465                                                GLRA1, GRIN2B, SRR                                                                                                                                               
  integrin binding                                                                        0.0198                                                                          6.9093                                                 FAP, IGF1, ACTN1, KDR                                                                                                                                            
  4 h                                                                                     Upregulated Genes                                                               GO_BP                                                  antigen processing and presentation of exogenous peptide antigen via MHC class I   0.0001                                  13.8031                               H2-K1, IFI30, FCER1G, FCGR1, FCGR3
  antigen processing and presentation of peptide antigen                                  0.0014                                                                          13.8031                                                SLC11A1, H2-AA, H2-AB1, CTSS                                                                                                                                     
  toll-like receptor 7 signaling pathway                                                  0.0014                                                                          13.8031                                                HAVCR2, UNC93B1, PIK3AP1, TLR7                                                                                                                                   
  GO_CC                                                                                   NLRP3 inflammasome complex                                                      0.0032                                                 11.3000                                                                            CASP4, GSDMD, PYCARD, CASP1                                                   
  AIM2 inflammasome complex                                                               0.0273                                                                          10.5938                                                CASP4, PYCARD, CASP1                                                                                                                                             
  CD95 death-inducing signaling complex                                                   0.0273                                                                          10.5938                                                CFLAR, CASP8, FAS                                                                                                                                                
  GO_MF                                                                                   IgG receptor activity                                                           0.0153                                                 13.6510                                                                            FCGRT, FCGR1, FCGR3                                                           
  peptidase activator activity involved in apoptotic process                              0.0153                                                                          13.6510                                                PYCARD, CTSC, CTSH                                                                                                                                               
  Fc-gamma receptor I complex binding                                                     0.0153                                                                          13.6510                                                LGALS3, FGR, FLNA                                                                                                                                                
  Downregulated Genes                                                                     GO_BP                                                                           regulation of synaptic transmission, dopaminergic      0.0059                                                                             23.2616                                 CNTNAP4, PNKD, CHRNA7                 
  positive regulation of long term synaptic depression                                    0.0097                                                                          18.6093                                                KCNB1, STAU2, IQSEC2                                                                                                                                             
  regulation of cAMP-mediated signaling                                                   0.0097                                                                          18.6093                                                PDE4A, PEX5L, RASD2                                                                                                                                              
  GO_CC                                                                                   cone cell pedicle                                                               0.0058                                                 23.5944                                                                            SLC32A1, RAPGEF4, PCLO                                                        
  synaptic cleft                                                                          0.0016                                                                          15.7296                                                CDH8, DNM3, GRIN2B, GRIN1                                                                                                                                        
  spectrin-associated cytoskeleton                                                        0.0139                                                                          15.7296                                                ANK1, ANK3, SPTB                                                                                                                                                 
  GO_MF                                                                                   voltage-gated cation channel activity                                           0.0099                                                 18.3642                                                                            GRIK1, GRIN2D, GRIN1                                                          
  NMDA glutamate receptor activity                                                        0.0017                                                                          15.3035                                                GRIN2B, GRIN2C, GRIN2D, GRIN1                                                                                                                                    
  oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor   0.0146                                                                          15.3035                                                TM7SF2, DHCR7, DHCR24                                                                                                                                            
  24 h                                                                                    Upregulated Genes                                                               GO_BP                                                  positive regulation of platelet activation                                         0.0000                                  20.5477                               PTPRJ, SELP, PLEK, PDPN, TLR4
  wound healing involved in inflammatory response                                         0.0069                                                                          20.5477                                                CD44, HMOX1, CCR2                                                                                                                                                
  positive regulation of monocyte aggregation                                             0.0069                                                                          20.5477                                                CD44, HAS2, NR4A3                                                                                                                                                
  GO_CC                                                                                   CHOP-C/EBP complex                                                              0.0062                                                 21.5356                                                                            CEBPA, CEBPB, DDIT3                                                           
  I-kappaB/NF-kappaB complex                                                              0.0009                                                                          17.2285                                                RELA, RELB, NFKB1, NFKB2                                                                                                                                         
  lamin filament                                                                          0.0196                                                                          12.9214                                                EIF6, LMNB1, LMNA                                                                                                                                                
  GO_MF                                                                                   CCR2 chemokine receptor binding                                                 0.0141                                                 14.9537                                                                            CCL12, CCL2, CCL7                                                             
  C-C chemokine binding                                                                   0.0022                                                                          13.2922                                                ZFP36, CCR5, CCR1, ACKR1                                                                                                                                         
  interleukin-1 receptor activity                                                         0.0022                                                                          13.2922                                                IL1R2, IL1R1, IL18RAP, IL1RAP                                                                                                                                    
  Downregulated Genes                                                                     GO_BP                                                                           intramembranous ossification                           0.0005                                                                             22.8308                                 CTSK, COL1A1, AXIN2, MMP2             
  regulation of endothelial cell proliferation                                            0.0005                                                                          22.8308                                                BMP4, ALDH1A2, TEK, KDR                                                                                                                                          
  urinary bladder development                                                             0.0080                                                                          20.5477                                                WNT5A, RBP4, TRP63                                                                                                                                               
  GO_CC                                                                                   synaptic cleft                                                                  0.0195                                                 13.4059                                                                            CDH8, GRIN2B, C1QL1                                                           
  AP-2 adaptor complex                                                                    0.0246                                                                          11.9164                                                EPS15, TBC1D5, SGIP1                                                                                                                                             
  microfibril                                                                             0.0362                                                                          9.7498                                                 LTBP1, FBN2, MFAP4                                                                                                                                               
  GO_MF                                                                                   GPI-linked ephrin receptor activity                                             0.0156                                                 14.9537                                                                            EPHA5, EPHA7, EPHA3                                                           
  platelet-derived growth factor binding                                                  0.0003                                                                          14.5383                                                COL3A1, COL1A2, PDGFRB, COL2A1, COL1A1                                                                                                                           
  G-protein coupled purinergic nucleotide receptor activity                               0.0054                                                                          10.7360                                                P2RY12, P2RY13, GPR34, P2RY14                                                                                                                                    
  3 d                                                                                     Upregulated Genes                                                               GO_BP                                                  antigen processing and presentation of exogenous peptide antigen via MHC class I   0.0002                                  12.7159                               H2-K1, IFI30, FCER1G, FCGR1, FCGR3
  antigen processing and presentation of peptide antigen                                  0.0018                                                                          12.7159                                                SLC11A1, H2-AA, H2-AB1, CTSS                                                                                                                                     
  positive regulation of neutrophil apoptotic process                                     0.0175                                                                          12.7159                                                CD44, ANXA1, HCAR2                                                                                                                                               
  GO_CC                                                                                   CHOP-C/EBP complex                                                              0.0162                                                 13.2493                                                                            CEBPA, CEBPB, DDIT3                                                           
  interleukin-6 receptor complex                                                          0.0162                                                                          13.2493                                                IL6, IL6ST, IL6RA                                                                                                                                                
  collagen type V trimer                                                                  0.0162                                                                          13.2493                                                COL5A3, COL5A2, COL5A1                                                                                                                                           
  GO_MF                                                                                   Fc-gamma receptor I complex binding                                             0.0178                                                 12.6146                                                                            LGALS3, FGR, FLNA                                                             
  peptidase activator activity involved in apoptotic process                              0.0178                                                                          12.6146                                                PYCARD, CTSC, CTSH                                                                                                                                               
  CCR5 chemokine receptor binding                                                         0.0001                                                                          10.8125                                                NES, CNIH4, STAT1, CCL5, CCL4, STAT3                                                                                                                             
  Downregulated Genes                                                                     GO_BP                                                                           spontaneous neurotransmitter secretion                 0.0111                                                                             16.0729                                 RIMS2, RIMS1, STX1B                   
  development of primary male sexual characteristics                                      0.0111                                                                          16.0729                                                WNT5A, SFRP1, SFRP2                                                                                                                                              
  positive regulation of protein kinase C activity                                        0.0213                                                                          12.0547                                                WNT5A, AGT, CEMIP                                                                                                                                                
  GO_CC                                                                                   GABA receptor complex                                                           0.0112                                                 16.0114                                                                            GABRG2, GABRA1, GABRB2                                                        
  synaptic cleft                                                                          0.0000                                                                          12.0086                                                CDH8, GRIN2B, GRIN1, C1QL1, GRIA3, ADGRB3                                                                                                                        
  kainate selective glutamate receptor complex                                            0.0343                                                                          9.6068                                                 GRIK1, GRIK5, GRIA4                                                                                                                                              
  GO_MF                                                                                   microsatellite binding                                                          0.0112                                                 16.0202                                                                            HEY1, HEY2, HEYL                                                              
  neurotransmitter binding                                                                0.0000                                                                          12.4602                                                GRIN2B, SLC6A11, GRIN2D, SLC6A13, GRIN1, ...                                                                                                                     
  NMDA glutamate receptor activity                                                        0.0000                                                                          12.0152                                                GRIN2B, GRIN2C, GRIN2D, GRIN1, GRIN3B, ...                                                                                                                       
  7 d                                                                                     Upregulated Genes                                                               GO_BP                                                  glycosaminoglycan metabolic process                                                0.0001                                  8.2679                                GNS, NDST1, HEXA, HEXB, FOXC1, CLN6
  positive regulation of platelet activation                                              0.0010                                                                          8.2679                                                 PTPRJ, SELP, PLEK, PDPN, TLR4                                                                                                                                    
  toll-like receptor 7 signaling pathway                                                  0.0064                                                                          8.2679                                                 HAVCR2, UNC93B1, PIK3AP1, TLR7                                                                                                                                   
  GO_CC                                                                                   death-inducing signaling complex                                                0.0001                                                 8.4970                                                                             CFLAR, CASP3, RIPK1, CASP8, FADD, FAS                                         
  ripoptosome                                                                             0.0001                                                                          8.4970                                                 CFLAR, RIPK1, TICAM1, CASP8, RIPK3, FADD                                                                                                                         
  condensin complex                                                                       0.0009                                                                          8.4970                                                 NCAPH, NCAPG, SMC2, SMC4, NCAPD2                                                                                                                                 
  GO_MF                                                                                   cysteine-type endopeptidase activity involved in execution phase of apoptosis   0.0398                                                 8.3235                                                                             CFLAR, CASP3, CASP7                                                           
  Fc-gamma receptor I complex binding                                                     0.0398                                                                          8.3235                                                 LGALS3, FGR, FLNA                                                                                                                                                
  nicotinate-nucleotide diphosphorylase (carboxylating) activity                          0.0398                                                                          8.3235                                                 NAMPT, QPRT, NAPRT                                                                                                                                               
  Downregulated Genes                                                                     GO_BP                                                                           positive regulation of long term synaptic depression   0.0002                                                                             11.6884                                 PPP1R9A, MAPT, KCNB1, STAU2, IQSEC2   
  regulation of cAMP-mediated signaling                                                   0.0002                                                                          11.6884                                                GNAI1, PDE4A, PDE10A, PEX5L, RASD2                                                                                                                               
  regulation of synaptic transmission, dopaminergic                                       0.0023                                                                          11.6884                                                CNTNAP4, PNKD, CHRNB2, CHRNA7                                                                                                                                    
  GO_CC                                                                                   GABA receptor complex                                                           0.0212                                                 11.5455                                                                            GABRG2, GABRA1, GABRB2                                                        
  juxtaparanode region of axon                                                            0.0000                                                                          9.2364                                                 EPB41L3, KCNAB2, KCNAB1, KCNA2, KCNA1, ...                                                                                                                       
  synaptic cleft                                                                          0.0002                                                                          8.6591                                                 CDH8, DNM3, GRIN2B, GRIN1, GRIA3, ADGRB3                                                                                                                         
  GO_MF                                                                                   netrin receptor activity                                                        0.0023                                                 11.6774                                                                            DCC, UNC5B, UNC5A, UNC5C                                                      
  AMPA glutamate receptor activity                                                        0.0023                                                                          11.6774                                                GRIA2, GRIA1, GRIA3, GRIA4                                                                                                                                       
  voltage-gated calcium channel activity involved in AV node cell action potential        0.0207                                                                          11.6774                                                CACNA1G, CACNB2, CACNA1C                                                                                                                                         
  28 d                                                                                    Upregulated Genes                                                               GO_BP                                                  response to interferon-beta                                                        0.0000                                  11.6059                               PLSCR1, IKBKE, IFNAR2, BST2, IFITM1, IFITM2, ...
  positive regulation of apoptotic cell clearance                                         0.0024                                                                          11.6059                                                CCL2, C3, MFGE8, C2                                                                                                                                              
  positive regulation of neutrophil apoptotic process                                     0.0210                                                                          11.6059                                                CD44, ANXA1, HCAR2                                                                                                                                               
  GO_CC                                                                                   CHOP-C/EBP complex                                                              0.0200                                                 11.9019                                                                            CEBPA, CEBPB, DDIT3                                                           
  ripoptosome                                                                             0.0006                                                                          9.9183                                                 CFLAR, RIPK1, TICAM1, CASP8, RIPK3                                                                                                                               
  NLRP3 inflammasome complex                                                              0.0052                                                                          9.5215                                                 CASP4, GSDMD, PYCARD, CASP1                                                                                                                                      
  GO_MF                                                                                   IgG receptor activity                                                           0.0212                                                 11.5231                                                                            FCGRT, FCGR1, FCGR3                                                           
  epidermal growth factor binding                                                         0.0212                                                                          11.5231                                                EGFR, SEC61B, SHC1                                                                                                                                               
  peptidase activator activity involved in apoptotic process                              0.0212                                                                          11.5231                                                PYCARD, CTSC, CTSH                                                                                                                                               
  Downregulated Genes                                                                     GO_BP                                                                           positive regulation of long term synaptic depression   0.0006                                                                             19.9801                                 PPP1R9A, KCNB1, STAU2, IQSEC2         
  JUN phosphorylation                                                                     0.0091                                                                          18.7314                                                MAPK8, MAPK10, MAPK8IP1                                                                                                                                          
  regulation of synaptic transmission, dopaminergic                                       0.0091                                                                          18.7314                                                CNTNAP4, PNKD, CHRNA7                                                                                                                                            
  GO_CC                                                                                   cone cell pedicle                                                               0.0089                                                 18.9058                                                                            SLC32A1, RAPGEF4, PCLO                                                        
  potassium channel complex                                                               0.0000                                                                          13.7497                                                KCNH1, KCNAB2, KCNAB1, KCNA2, KCNA6, ...                                                                                                                         
  NMDA selective glutamate receptor complex                                               0.0001                                                                          12.6038                                                DLGAP3, GRIN2B, GRIN2C, GRIN2D, GRIN1, ...                                                                                                                       
  GO_MF                                                                                   netrin receptor activity                                                        0.0091                                                 18.7457                                                                            DCC, UNC5B, UNC5C                                                             
  NMDA glutamate receptor activity                                                        0.0002                                                                          15.6214                                                GRIN2B, GRIN2C, GRIN2D, GRIN1, GRIN3A                                                                                                                            
  voltage-gated cation channel activity                                                   0.0147                                                                          14.9966                                                GRIK1, GRIN2D, GRIN1                                                                                                                                             

DAVID analysis was performed for upregulated DEGs with the same direction of variation at each time point after SCI (see **Tables [1](#T4){ref-type="table"}** and **[2](#T5){ref-type="table"}** for details). Accordingly, many inflammation-related pathways were upregulated in injured spinal cord. One pathway showing the greatest change in gene expression profiling was the tumor necrosis factor signaling pathway. Inflammatory response was also top-listed when GO_BP terms were sorted by the number of enriched genes. For these inflammation-related genes, higher expression levels were maintained in the SCI animal model for at least 28 days. Thus, we next focused on these genes. A striking finding was that some C-C motif chemokine-ligand genes were markedly upregulated at each time point. Among these, CCL3 showed obvious upregulation within 30 minutes after SCI, with at least a 6-fold increase in expression at each time point until day 28. Additionally, the Timp3 gene, a tissue inhibitor of metalloproteinases, was found to be upregulated at each time point.

###### 

Top-20 KEGG terms of upregulated differentially expressed genes with the same variation tendency at each time point after spinal cord injury

  KEGG terms                                  *P*    Fold enrichment   Gene symbols
  ------------------------------------------- ------ ----------------- ---------------------------------------------------------------------------------------
  TNF signaling pathway                       0      14.85             CXCL1, FOS, CCL12, ICAM1, CEBPB, CCL2, PTGS2, SOCS3, JUN, MAP3K8, BIRC3, JUNB, CXCL10
  Rheumatoid arthritis                        0      13.67             CCL12, FOS, ICAM1, CCL3, CCL2, JUN, TLR2, H2-AA, H2-AB1
  Leishmaniasis                               0      13.62             FOS, PTGS2, JUN, TLR2, H2-AA, H2-AB1, ITGAM
  Malaria                                     0      12.97             CCL12, ICAM1, CCL2, TLR2, THBS1
  Thyroid cancer                              0.02   12.88             TRP53, NRAS, MYC
  Staphylococcus aureus infection             0      12.45             ICAM1, C5AR1, H2-AA, H2-AB1, ITGAM
  Bladder cancer                              0      12.15             TRP53, NRAS, THBS1, MYC
  Inflammatory bowel disease                  0      10.55             JUN, TLR2, H2-AA, H2-AB1, STAT3
  Toll-like receptor signaling pathway        0      9.86              FOS, CCL3, JUN, MAP3K8, TLR2, CCL4, CD14, CXCL10
  Salmonella infection                        0      9.58              CXCL1, FOS, CCL3, JUN, CCL4, CD14
  Legionellosis                               0.01   8.74              CXCL1, TLR2, ITGAM, CD14
  Chagas disease (American trypanosomiasis)   0      8.46              CCL12, FOS, CCL3, CCL2, JUN, SERPINE1, TLR2
  Pertussis                                   0      8.41              FOS, ITGA5, JUN, ITGAM, CD14
  Colorectal cancer                           0.01   7.78              TRP53, FOS, JUN, MYC
  p53 signaling pathway                       0.02   7.43              TRP53, SERPINE1, GADD45G, THBS1
  Small cell lung cancer                      0      7.41              TRP53, PTGS2, BIRC3, MYC, FN1
  Hepatitis B                                 0      6.82              TRP53, NRAS, FOS, EGR2, JUN, TLR2, MYC, STAT3
  Prolactin signaling pathway                 0.02   6.82              NRAS, FOS, SOCS3, STAT3
  mmProteoglycans in cancer                   0      6.75              TRP53, NRAS, ITGA5, TLR2, THBS1, SDC4, MYC, TIMP3, STAT3, FN1, PLAUR
  Phagosome                                   0      6.44              ITGA5, TLR2, TUBB6, H2-AA, H2-AB1, THBS1, ITGAM, SEC61A1, CD14

*P* \< 0.05, sorted by fold enrichment scores. KEGG: Kyoto Encyclopedia of Genes and Genomes; TNF: tumor necrosis factor; STAT: signal transducer and activator of transcription.

###### 

Top-three GO terms with highest fold enrichment scores of differentially expressed genes with the same variation tendency at each time point after spinal cord injury

                                                                                            GO terms                 *P*                                                         Fold enrichment    Gene symbols
  ------------------------------------------------------- --------------------------------- ------------------------ ----------------------------------------------------------- ------------------ ----------------
  Upregulated genes                                       BP                                Response to vitamin b3   0.01                                                        179.03             TRP53, CCL2
  Positive regulation of cell aging                       0.01                              179.03                   TRP53, LMNA                                                                    
  Negative regulation of natural killer cell chemotaxis   0.02                              119.35                   CCL12, CCL2                                                                    
  CC                                                      Ribonucleoprotein complex         0.02                     127.26                                                      ZFP36, ELAVL1      
  Fibrinogen complex                                      0.04                              54.54                    THBS1, FN1                                                                     
  Phagocytic vesicle membrane                             0.02                              12.18                    TLR2, RAB20, SEC61A1                                                           
  MF                                                      Ccr2 chemokine receptor binding   0.02                     87.23                                                       CCL12, CCL2        
  Ccr5 chemokine receptor binding                         0                                 74.77                    NES, CCL4, STAT3                                                               
  Lipoteichoic acid binding                               0.03                              58.15                    TLR2, CD14                                                                     
  Downregulated genes                                     BP                                Suckling behavior        0.02                                                        111.96             GRIN2B, POU4F1
  MF                                                      Ligase activity                   0.04                     8.5                                                         DTX1, MID1, TTC3   
  Zinc ion binding                                        0                                 6.68                     TRHDE, GRIN2B, DTX1, AGBL5, DNAJC21, MID1, TTC3                                
  Metal ion binding                                       0.01                              2.75                     TRHDE, PDP2, GRIN2B, DTX1, DGKG, AGBL5, MID1, TTC3, CDH10                      

*P* \< 0.05, sorted by fold enrichment score. GO: Gene Ontology; STAT: signal transducer and activator of transcription.

Protein-protein interactions {#sec2-8}
----------------------------

A protein-protein interaction network was constructed based on expression changes of DEGs with the same direction of variation at each time point after SCI (**[Figure 4A](#F4){ref-type="fig"}**). The network contained 84 nodes and 410 pairs of connections. The 10 DEGs showing the highest degrees of change were: JUN, FOS, TRP53, PTGS2, CCL2, MYC, TLR2, STAT3, ATF3, and ICAM1, all of which primarily participate in the cytokine response.

![Interaction networks of DEGs with the same variation tendency at each time point of SCI.\
(A) Interaction network of DEGs with the same variation tendency at each time point of SCI compared with the control group. Circles represent DEGs (red for upregulated DEGs and green for downregulated DEGs) and lines represent interactions. (B) Interaction network of upregulated DEGs with the same variation tendency at each time point of SCI compared with the control group. Circles represent DEGs (red for upregulated DEGs and yellow for transcription factors). DEGs: Differentially expressed genes; SCI: spinal cord injury.](NRR-14-1262-g005){#F4}

To investigate transcriptome changes after SCI, AnimalTFDB 2.0 was used for transcription factor prediction. To investigate transcriptional activity of transcription factors, we constructed an interaction network from DEGs that were upregulated at various time points. Several transcription factors were found among these DEGs. The network contained 399 regulation modes and 77 nodes involving 15 transcription factors (**[Figure 4B](#F4){ref-type="fig"}**). Because DEGs with higher-degree distributions may play more important roles in SCI pathogenesis, we reviewed gene expression of transcription factors with the highest degrees. Overall, the 10 upregulated DEGs with the highest degrees were: JUN, FOS, TRP53, PTGS2, CCL2, MYC, TLR2, STAT3, ATF3 and ICAM1, six of which are transcription factors. Among these transcription factors, ATF3 exhibited the greatest change (almost 64-fold increase). Indeed, it was upregulated within 30 minutes after SCI, and its expression levels remained high even on day 28.

Discussion {#sec1-4}
==========

Spinal cord injury can result in neurological dysfunction involving locomotor, sensory, and autonomic systems. Therefore, understanding its pathogenesis is crucial for further strategies aimed at prevention and therapies. In this study, we used gene expression profiling to identify and characterize a number of DEGs in the T8 segment of the spinal cord at different time points following injury. At each time point, the majority of these DEGs were upregulated, suggesting a greater amount of transcriptional activation.

Notably, KEGG analysis revealed that genes related to metabolic pathways were downregulated on day 7, when the largest number of enriched genes was observed, which was the same on day 28. Moreover, our results show that genes related to inflammatory processes were upregulated within 30 minutes, and continued to be upregulated on even day 28 after SCI, with a peak on day 7. Therefore, inflammation-related pathways were retrieved for Mus musculus (mouse) from the KEGG website (<http://www.kegg.jp/>). DAVID bioinformatics analysis revealed that almost half of these pathways were enriched for DEGs related to inflammation. Among these pathways, the tumor necrosis factor signaling pathway, rheumatoid arthritis, inflammatory bowel disease, toll-like receptor signaling pathway, phagosome, nuclear factor-kappa B signaling pathway, chemokine signaling pathway, cell adhesion molecules, MAPK signaling pathway, *Staphylococcus aureus* infection, and HTLV-I infection were identified.

Injury can elicit inflammatory stimuli, which then induce pathological accumulation and proliferation of inflammatory cells, a process that involves neutrophils, macrophages/microglia, and astrocytes (Liu et al., 1997; Carlson et al., 1998; Schnell et al., 1999; Hashimoto et al., 2003, 2005; Peifer et al., 2006; Ghasemlou et al., 2010; Nishimura et al., 2013). Naturally, various mediators are released into the microenvironment, including proinflammatory chemokines/cytokines and proteases (Peifer et al., 2006; Rice et al., 2007). Localized immune/inflammatory responses exacerbate the initial damage and contribute to secondary tissue damage after SCI, which can then result in functional deficits (Ghasemlou et al., 2010). However, these inflammatory responses are also essential for cleaning tissue debris and remodeling and repair after injury. Specifically, neutrophil invasion appears at approximately 6 hours after SCI, as evidenced by upregulation of inflammatory cytokines (Liu et al., 2002), such as interleukin-1α, interleukin-1β, interleukin-6, and tumor necrosis factor α. At 1 day after SCI, neutrophil number reaches peak levels at the injury site (Carlson et al., 1998; Schnell et al., 1999). Meanwhile, macrophages start to emerge at 3 days, reaching a peak at 7 days (Zhu et al., 2017). Macrophages may produce mediators that contribute to subsequent processes. Macrophage infiltration into the injury site at 7 days is best described as foam cells (Zhu et al., 2017), whose function largely depends on the surrounding microenvironment (Amit et al., 2016). Moreover, Guerrero et al. (2012) indicated that blockade of the interleukin-6 pathway in macrophages may promote regeneration of the spinal cord in mice. After the inflammatory reaction, the residual area is surrounded by glial scarring. Astrocytes begin to increase after SCI by day 2 and high numbers are maintained for at least 14 days (Baldwin et al., 1998), a situation that can produce potent inhibitors of neurite outgrowth (Wanner et al., 2013). Moreover, inducible nitric oxide synthetase is synthesized in glial scars, while regeneration of spinal cord tracts is inhibited by glial scar formation. Hence, the lesion phase can be divided into three stages (Hashimoto et al., 2005). First, neutrophils infiltrate and cell death dramatically increases (Liu et al., 1997). Subsequently, macrophages/microglia accumulate and proliferate, which may have dual effects on surrounding tissue. Glial scar formation comprises the final stage, and astrocytes hinder tract regeneration by surrounding the injured tissue and producing scar-associated compounds.

These findings led us to investigate the function of persistent dysregulated genes in the spinal cord after injury. In this study, we identified 109 upregulated genes and 30 downregulated genes that maintain the same variation tendency at each time point. Subsequently, we performed DAVID analysis separately for up- and downregulated DEGs. Not surprisingly, our results show that many inflammation-related pathways are upregulated in the injured spinal cord. The tumor necrosis factor signaling pathway exhibited the greatest change, with high expression levels of inflammation-related genes of this pathway lasting for at least 28 days in our SCI model mice. Strikingly, some C-C motif chemokine ligand genes were also markedly upregulated. Among these, the CCL3 gene showed the most obvious upregulation, beginning within 30 minutes after SCI and lasting for as long as 28 days (more than a 6-fold increase at each time point). This gene participates in the toll-like receptor signaling pathway, cytokine-cytokine receptor interaction, and the chemokine signaling pathway. CCL2 and CCL12 are involved in the tumor necrosis factor signaling pathway, nuclear factor-kappa B signaling pathway, and chemokine signaling pathway. Moreover, it has been reported that matrix metalloproteinases (MMPs) regulate inflammation after SCI (Zhang et al., 2011). Appropriately, our results show that MMP2 and MMP14 are upregulated at every time point. Additionally, TIMP3 (a tissue inhibitor of metalloproteinases) was also upregulated. Because inflammation-related genes and inflammatory responses participate in injury processes, our results provide potential targets for molecular therapies aimed at regulating inflammation.

To investigate transcriptome changes after SCI, transcription factors were predicted based on AnimalTFDB 2.0. An interaction network of upregulated DEGs at each time point was then constructed, with transcription factors identified among these DEGs. The network contained 399 regulation nodes, which was far more than expected. The network also showed that 15 transcription factors were involved in 77 nodes. Moreover, 6 of the 10 upregulated DEGs showing the highest degrees of distribution were transcription factors. Consequently, we focused on transcription factors with higher-degree distributions because these DEGs may play important roles in SCI pathogenesis. Among these six transcription factors, ATF3 showed the greatest change (almost 64-fold increase), which began within 30 minutes after SCI and was still high at 28 days. Thus, according to our network analysis, we predict that ATF3 is the key transcription factor, showing long-term increased expression and interacting with many proteins.

As an activating transcription factor, ATF3 may play important roles in inflammation and carcinogenesis in various diseases (Gilchrist et al., 2006; Lin et al., 2014; Huang et al., 2015; Rao et al., 2015; Bar et al., 2016; Iezaki et al., 2016; Mallano et al., 2016; Udayakumar et al., 2016; Wang et al., 2016; Kaitu'u-Lino et al., 2017; Kim et al., 2017). ATF3 can be induced by the toll-like receptor signaling pathway, and in turn, appears to negatively regulate toll-like receptor-stimulated inflammatory responses (Gilchrist et al., 2006). ATF3 can translocate into the nucleus and recruit histone deacetylase-1 to the promoter of interleukin-6 and tumor necrosis factor, ultimately repressing their expression (Gilchrist et al., 2006). Lai et al. (2013) have already shown that ATF3 regulates the release of some inflammatory molecules to reduce lung injury and decrease mortality rate of mice challenged by lipopolysaccharide. ATF3 can also bind DNA sites with Jun to form homo- or hetero-dimers (Tsujino et al., 2000; Koh et al., 2010). The Jun family protein members may participate in the MAPK signaling pathway, which can be induced in response to neuronal injury (Raivich et al., 2004). These genes were also upregulated at every time point and showed higher degrees in our network analysis, which is consistent with previous studies. Additionally, ATF3 can regulate two aspects of the neutrophil response: inhibition of neutrophil chemokine production and promotion of neutrophil chemotaxis (Boespflug et al., 2014). Furthermore, ATF3 can regulate the canonical transforming growth factor-β signaling pathway in systemic sclerosis and might be a potential target for therapy (Mallano et al., 2016). However, its function in the pathogenesis of SCI has not been fully investigated (Seijffers et al., 2007). Tsujino et al. (2000) suggested that ATF3 connects with SOCS3, which is induced in neurons after SCI. ATF3 has also been proposed to be a potent marker of nerve injury and a novel marker for regeneration (Lindå et al., 2011). STAT3 is an important transcription factor during SCI and also a potential target for therapy (Herrmann et al., 2008).

More or less inevitably, patients with traumatic SCI suffer from locomotor deficits throughout their lives. Currently, no pharmacological or biological therapies have proven to be clinically effective. Moreover, collecting spinal cord samples from SCI patients or administering experimental treatments is not possible. To date, scientific investigation of SCI pathology and therapies have depended mostly on animal models of SCI (Kwon et al., 2010). Therefore, animal models provide promising hints regarding effective therapies and the mechanisms underlying SCI. In this study, our results were obtained at multiple time points, with biological repetitions at each time point. Potential genes related to SCI were screened using bioinformatic methods. Therefore, changes in gene expression after SCI were analyzed from multiple levels. Nonetheless, limitations of microarray analyses should be considered. First, we focused on tissue at the injury site, not one specific cell type. Therefore, different cells types will have contributed to RNA expression profiling as a whole, yet may play distinct functions. Targeting specific cells of interest for thorough analyses may yield more valuable results (Greenhalgh and David, 2014; Sofroniew, 2015). Nonetheless, clarification and comprehensive understanding of these molecular events are indispensable at a systemic level. Additionally, the dataset was retrieved from the existent Gene Expression Omnibus Database, and only moderate damage was introduced in our experimental approach. If more degrees of damage and injury sites were analyzed, again the results and conclusions may be more meaningful. Thus, further relevant studies are needed for validation and enhancement of practical significance at various levels, including animal models and cellular experiments. Despite these limitations, our results may be helpful for clarifying the pathological reaction and exploring new therapeutic approaches for SCI.

Taken together, gene expression profiling was noticeably altered at different time points/stages following SCI. The most remarkably upregulated DEGs were found to be associated with inflammation, including transcription factors such as ATF3. These essential genes can be considered as candidate targets for treatment of SCI. Further experiments, including functional studies, are necessary to integrate various types of data and reveal the exact underlying mechanisms in animal models before any clinical use.
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